Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline and Fluticasone in COPD
NCT00241631Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Apr 2006
- Primary completion
- Aug 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of theophylline and fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by Imperial College London. Primary endpoint: Sputum Inflammatory Cell Counts at 10 weeks. Started Apr 2006; status: completed.
02
Drugs
theophyllinefluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00241631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241631.